Filter Articles
March 19, 2018
FDA approves CSL Behring treatment for CIDP
The Food and Drug Administration granted marketing clearanceย Fridayย for Hizentra, a treatment for chronic inflammatory demyelinatingโฆ
The Food and Drug Administration granted marketing clearanceย Fridayย for Hizentra, a treatment for chronic inflammatory demyelinatingโฆ